FDA Approves New Drug For Leukemia

AML is a rapidly progressing cancer that crowds out normal cells in the bone marrow and bloodstream, resulting in low numbers of normal blood cells and a continuous need for transfusions, reports...

from NDTV News - Latest https://ift.tt/2DSipdT